Evidence map›Paper›PMID 41748728›Full record

ArticleCommunications biology2026

ATPase N-ethylmaleimide-sensitive factor mediated calcium dependent fusion pore closure and endocytosis.

Yudong Wang, Siyang Ma, Shuo Song, Chengmu Zhao, Yu Wang, Bo Liu, Wanchun Huang, Hongfang Li, Xin Wang, Dejuan Zhi and 1 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yudong Wang *School of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.ORCID http://orcid.org/0000-0002-7658-4108
Siyang Ma *School of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.
Shuo Song *School of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.
Chengmu ZhaoSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.
Yu WangSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.
Bo LiuSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.
Wanchun HuangSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China.
Hongfang LiSchool of Basic Medical Science, Lanzhou University, Lanzhou, Gansu, P. R. China.
Xin WangSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China. wx@lzu.edu.cn.
Dejuan ZhiSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China. zhidej@lzu.edu.cn.ORCID http://orcid.org/0000-0002-1787-3735
Dongsheng WangSchool of Pharmacy, Joint Drug Development and Innovation Centre for Neurological Disorders of Lanzhou University-China National Biotec Group-Lanzhou Biotechnology Development Co., Lanzhou University, Lanzhou, Gansu, P. R. China. dswang@lzu.edu.cn.ORCID http://orcid.org/0000-0002-3898-4426

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82073825
6 · The paper itself

Abstract

For a long time, it remained an unresolved question how the fusion pore is regulated to close after fusion occurs during kiss-and-run. Our study focuses on the physiological function of NSF in modulating single vesicle fusion events in live cells, using whole-cell capacitance recording coupled with live-cell confocal imaging. Our results demonstrates that in both male Sprague-Dawley rat adrenal chromaffin endocrine cells and dorsal root ganglion neurons, inhibiting or diminishing the ATPase activity of NSF significantly impedes fusion pore closure, inhibits various forms of endocytosis, and disrupts the replenishment of readily releasable pool. Interestingly, NSF is exclusively required for calcium-dependent exo-endocytosis but not for the calcium-independent process. In response to calcium influx, NSF disassembles the trans-SNARE complex intermediate via its ATPase activity, which regulates fusion pore closure and subsequently mediates slow, fast, and overshoot endocytosis. Our findings revealed a key mechanism for fusion pore regulation in calcium-evoked exo-endocytosis coupling.

Indexed as

CalciumChromaffin CellsEndocytosisMembrane FusionN-Ethylmaleimide-Sensitive ProteinsAnimalsGanglia, SpinalMaleNeuronsRatsRats, Sprague-DawleyCalciumN-Ethylmaleimide-Sensitive Proteins

Identifiers

PMID41748728
PMCPMC13057476

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.